BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 24629518)

  • 21. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
    Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
    J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
    Zuriel D; Fink-Puches R; Cerroni L
    Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
    Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
    Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
    Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
    Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
    Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
    Br J Dermatol; 2015 Jul; 173(1):134-45. PubMed ID: 25556641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extranodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous breast involvement].
    Fréling E; Granel-Brocard F; Serrier C; Ortonne N; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2015 Feb; 142(2):104-11. PubMed ID: 25554664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
    Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
    Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
    Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
    Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.
    Meneses-García A; Betancourt AM; Abarca JH; Montes AB; Roa LS; Ruíz-Godoy L
    World J Surg Oncol; 2008 Oct; 6():114. PubMed ID: 18954439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
    Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
    J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.
    Fried I; Artl M; Cota C; Müller H; Bartolo E; Boi S; Chiarelli C; Vale E; Schmuth M; Wiesner T; Speicher MR; Cerroni L
    J Am Acad Dermatol; 2014 Apr; 70(4):716-723. PubMed ID: 24433873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current management of nasal NK/T-cell lymphoma.
    Au WY
    Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
    Yu JB; Zuo Z; Tang Y; Zhao S; Zhang YC; Bi CF; Wang WY; Zhang WY; Wang L; Liu WP
    Hum Pathol; 2009 Jun; 40(6):807-16. PubMed ID: 19200574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of locally invaded sites and tissue types in patients with nasal extranodal natural-killer/T-cell lymphoma: a single-center retrospective analysis.
    Dong GH; Li Y; Dong JY; Li X; Wan HF; Yang L; Wang JW; Gong LP; Zhao YH; Zhang H; Gao ZF; Liu HG
    Chin Med J (Engl); 2019 Jun; 132(11):1305-1313. PubMed ID: 31009392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.